Nureca Limited has informed the Exchange regarding a press release dated April 12, 2025, titled "Nureca Limited s Manufacturing Subsidiary Secures US FDA Registration".
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nureca Limited announced that its manufacturing subsidiary has received US FDA registration, as per a press release dated April 12, 2025. FDA registration is a regulatory requirement for companies that manufacture or distribute products intended for sale in the United States. This milestone allows the subsidiary to legally produce and supply its products to the US market. The filing was shared with the exchange for disclosure purposes. No specific financial figures, order values, or timelines were mentioned in the announcement.
This is a positive development as it opens the door for Nureca's subsidiary to manufacture and sell products in the large US market, potentially expanding revenue streams. However, FDA registration alone does not guarantee immediate business — it is a necessary first step, and investors should watch for actual product approvals and sales traction.